HighTower Advisors LLC Purchases New Shares in LifeVantage Co. (NASDAQ:LFVN)

HighTower Advisors LLC acquired a new position in shares of LifeVantage Co. (NASDAQ:LFVN) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 52,743 shares of the company’s stock, valued at approximately $638,000. HighTower Advisors LLC owned 0.42% of LifeVantage as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Capital Management Corp VA acquired a new position in shares of LifeVantage during the 3rd quarter worth about $5,073,000. Renaissance Technologies LLC boosted its holdings in LifeVantage by 2.1% in the 2nd quarter. Renaissance Technologies LLC now owns 855,118 shares of the company’s stock worth $5,490,000 after buying an additional 17,300 shares during the last quarter. Hantz Financial Services Inc. purchased a new stake in LifeVantage during the 2nd quarter worth approximately $91,000. Finally, Ritholtz Wealth Management raised its holdings in shares of LifeVantage by 62.0% during the third quarter. Ritholtz Wealth Management now owns 28,666 shares of the company’s stock valued at $346,000 after acquiring an additional 10,974 shares during the last quarter. 35.32% of the stock is owned by hedge funds and other institutional investors.

LifeVantage Stock Up 15.5 %

LifeVantage stock opened at $17.73 on Friday. The company has a fifty day simple moving average of $13.88 and a 200-day simple moving average of $10.24. The firm has a market capitalization of $222.07 million, a price-to-earnings ratio of 55.41 and a beta of 0.87. LifeVantage Co. has a 52-week low of $5.22 and a 52-week high of $18.41.

LifeVantage (NASDAQ:LFVN) last released its quarterly earnings data on Tuesday, October 29th. The company reported $0.15 EPS for the quarter, meeting analysts’ consensus estimates of $0.15. The company had revenue of $47.21 million during the quarter. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%.

LifeVantage Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Shareholders of record on Monday, December 2nd were paid a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.90%. The ex-dividend date of this dividend was Monday, December 2nd. LifeVantage’s dividend payout ratio (DPR) is currently 50.00%.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital began coverage on LifeVantage in a research note on Thursday. They issued a “buy” rating and a $26.00 price target on the stock.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.